EuroHYP-1: Funding Decision awaited
The deadline for applications in the second round of the FP7 call has now passed, and the EuroHYP team have worked hard to put the final touches to our application, submitted on 10th February. We await the funding decision secure in the knowledge that we have submitted an application which reflects the promise of hypothermia as a treatment for stroke, as well as the potential of the EuroHYP team to deliver a practice- changing clinical trial.
We are extremely grateful to the researchers, colleagues, patient representatives, SMEs and others who have been with us on the journey so far and have contributed so much to what is shaping up to be a pivotal trial of this highly promising treatment. Special thanks to the European Stroke Organisation, the Stroke Alliance for Europe, ECRIN, and the FP7 National Contact Points who have been so helpful.
Details of the Trial Protocol will shortly be launched on this website. Centres wishing to join the trial should email for further details including contact email for their National Co-ordinator and to be given access to a simple online eligibility questionnaire.
EuroHYP has attracted a great deal of press attention, some of which is given on the Press page.
You can contact EuroHYP by email here.